Qube Research & Technologies (QRT)’s Oculis Holding OCS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OCS Stock Details OCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$545K	Buy	+20,490	New	+$542K	﹤0.01%	2710

Other funds holding OCS

EFM

EQT Fund Management Luxembourg $1.02B AUM

Gildi lifeyrissjodur Reykjavik $197M AUM

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OCS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Oculis Holding (OCS) in Q1 2026: 20,490 shares worth $545K. The stake represents ﹤0.01% of the portfolio and ranks #2710 among its holdings.

57 funds tracked by Wall St. Rank hold OCS as of Q1 2026.

Qube Research & Technologies (QRT) held 20,490 shares of Oculis Holding worth $545K as of Q1 2026.
Oculis Holding was a new Qube Research & Technologies (QRT) position in Q1 2026.
Oculis Holding made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2710 holding.
57 funds tracked by Wall St. Rank held Oculis Holding as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.